Early evidence suggests GLP-1s were linked to lower risks of developing substance use disorders — from alcohol to opioids — and to fewer overdoses and deaths in people with existing addictions.

Understanding what the US spends to treat mental health and substance use disorders (SUD) is important for understanding spending patterns and informing health policy. In this study, we determined ...

There’s ‘no evidence’ marijuana works to treat most mental health disorders, largest review of its kind finds - More than 52 ...

Patients who are prescribed higher daily doses of the medication buprenorphine for opioid use disorder are significantly more ...

Attention-deficit/hyperactivity disorder (ADHD) is a common neurodevelopmental disorder, affecting 12%–13% of adolescents in the United States, according to some studies. The pattern of inattention, ...

The FDA has not approved leucovorin for the treatment of autism, though some experts are still seeing an increase in prescription requests.

Attention-deficit/hyperactivity disorder (ADHD) is a common neurodevelopmental disorder, affecting 12%–13% of adolescents in the United States, according to some studies.

Owners of the ORO Apartments are represented by attorney John DiLorenzo, who's previously tangled with the city over issues of unsheltered homelessness.

The ACLU is suing the state of West Virginia for its moratorium on methadone clinics, a practice that cuts the risk of ...

Iowa House lawmakers passed a bill making the plant-based stimulant kratom a Schedule I controlled substance. The bill now goes to the Senate.

Oceanside, CA - March 18, 2026 - PRESSADVANTAGE - Moment of Clarity has released a new educational resource examining ...

The national Six Remnant Defendants lawsuit was brought Feb. 23. The total compensation paid to participating governments ...